PT  - JOURNAL ARTICLE
AU  - Murillo-Zamora, Efrén
AU  - Hernandez-Suarez, Carlos
TI  - Performance of suspected influenza case definition before and during the COVID-19 pandemic
AID  - 10.1101/2020.06.01.20119446
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.06.01.20119446
4099  - http://medrxiv.org/content/early/2020/06/02/2020.06.01.20119446.short
4100  - http://medrxiv.org/content/early/2020/06/02/2020.06.01.20119446.full
AB  - Background The influenza-related burden remains high and the COVID-19 pandemic may difficult its accurate surveillance. This study aimed to evaluate the performance, before and during the COVID-19 pandemic, of the case definition of suspected influenza used in community surveillance in Mexico. Methods: A cross-sectional analysis of a cohort study took place and cases fulfilling the suspected case criteria (n = 20, 511), and with laboratory-conclusive evidence (quantitative real-time polymerase chain reaction) to confirm or discard influenza virus infection, were analyzed.Results A high sensitivity and modest specificity was documented, and this later decreased during the COVID-19 outbreak, as well as its diagnostic accuracy. However, no significant differences were observed in the Area Under the Receiver Operating Characteristics among the analyzed periods.Conclusions The evaluated case definition remains to be a cost-effective alternative to identify patients who may benefit from influenza-specific antiviral drugs, even during the COVID-19 global outbreak.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis is an observational study.Funding StatementNone to declareAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Local Ethics in Health Research Committee (601) of the Mexican Institute of Social Security (R-2020-601-022).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.